LetsGetChecked Valuation, Funding & Investors

LetsGetChecked is valued at $1B as of June 2021.

Last LetsGetChecked valuation

$1B

Series D · Jun 2021

Last LetsGetChecked funding round

$165M

Series F · Jan 2025

Cumulative funding LetsGetChecked raised

$598M

across 7 funding rounds

Key investors in LetsGetChecked

  • Optum Ventures
  • Illumina Ventures
  • Transformation Capital
  • Common Fund
  • Qiming Venture Partners
  • Casdin Capital

LetsGetChecked Overview

About LetsGetChecked

LetsGetChecked is a direct-to-consumer health testing service delivering at-home kits for lab analysis in wellness, sexual health, hormones, and chronic conditions. Samples process through CLIA-certified labs with physician-reviewed results via app within 2-5 days. Dublin-headquartered since 2015, it operates in the United States, Canada, and Europe, partnering with insurers like Cigna and employers for corporate wellness programs. LetsGetChecked ships kits nationwide and supports telehealth consultations.


Founded

2015

HQ

United StatesAtlanta, GA

Status

Privately held

Customer focus

B2C & B2B

Revenue model

Product sales

Valuation

$1B (Jun 2021)

LetsGetChecked Valuation

LetsGetChecked is currently valued at $1B, based on its Series D in June 2021.

The $150M round was led by Casdin Capital, with participation from Illumina Ventures, HLM Venture Partners, Symphony Ventures, Synetro Group, Qiming Venture Partners USA and 3 other investors.

LetsGetChecked valuation by funding round

LetsGetChecked valuation by funding round
DateStageValuation
Jun 2021Series D$1B

LetsGetChecked Funding History

LetsGetChecked has raised a total of $598M across 7 funding rounds.

LetsGetChecked's first fundraising round was a $12M Series A in March 2018. The most recent completed round was a $165M Series F in January 2025.

LetsGetChecked funding rounds

LetsGetChecked funding rounds
DateStageInvestorsRaisedValuationDeal Summary
Jan 2025Series FOptum Ventures (lead)$165M-The company, founded in 2015 and headquartered in Dublin and New York, provides at-home testing kits, telehealth, and pharmacy services, partnering with United Healthcare, Optum, CVS Pharmacy, and over 300 corporate customers, employing over 350 people. The closest prior event is the 2021 Series D round of $150M led by Casdin Capital with Optum Ventures participation, achieving unicorn status at over $1B valuation, used to expand at-home testing for conditions like cholesterol, diabetes, and Covid-19, with 1,500% YoY revenue growth and 2.3M tests performed at that time. In August 2024, LetsGetChecked agreed to acquire Truepill, a US digital pharmacy, for a $525M headline value structured as $25M cash plus stock and up to $200M earnouts tied to revenue milestones, financed partly by a $150M convertible note offering. Both companies, backed by Optum Ventures, faced cash burn issues; the deal forms a new entity initially using the Truepill name with most of Truepill's senior management retained, aiming to integrate testing and pharmacy services for better efficiency, especially amid demand for GLP-1 medications. Truepill, previously valued at $1.6B in 2021 after $370M in VC, had been shopped since March 2024.
Aug 2024Undisclosed stage-$150M-LetsGetChecked, an Irish digital health company founded in 2015 by Peter Foley and dually headquartered in Dublin and New York, provides at-home testing kits for hormones, fertility, HPV, cholesterol, diabetes, and pivoted to Covid-19 testing during the pandemic. The company achieved unicorn status in 2021 with a $1 billion valuation following a $150 million Series D led by Casdin Capital and later secured $20 million from Morgan Health in a Series D2. In August 2024, LetsGetChecked agreed to acquire US digital pharmacy Truepill for a headline $525 million, structured as $25 million cash, stock for the balance, and up to $200 million earnouts tied to revenue milestones, financed partly by a $150-165 million convertible note offering. Both companies, backed by Optum Ventures, face cash burn challenges. Internal financials show LetsGetChecked lost $32 million on $39 million in revenue over the first five months of 2024, indicating a declining revenue run rate. Truepill, meanwhile, lost $15 million on $64 million revenue in the first four months of 2024 with an increasing run rate. The deal creates a merged entity under a NewCo, initially using the Truepill name and retaining most of Truepill's senior management including CEO Paul Greenall, to integrate at-home testing with digital pharmacy fulfillment and improve operations amid insurer interest in treatments like GLP-1 drugs. Truepill, based in Hayward, California, had raised over $370 million in VC and reached a $1.6 billion valuation in 2021 from investors like a16z, Oak HC/FT, and Initialized Capital, but lost unicorn status. LetsGetChecked has raised over $200 million historically. The acquisition aims to enhance patient data integration, reduce outsourcing costs, and bolster customer experience, with no disclosed closing date or regulatory reviews. Reports indicate LetsGetChecked raised $165 million in new financing to support the transaction.
Sep 2022Series DCasdin Capital (lead); Transformation Capital (lead); Rory McIlroy; Illumina Ventures; Morgan Health; Common Fund$20M-LetsGetChecked is a Dublin, Ireland- and New York-based virtual care company that builds and delivers at-home testing kits including hormone tests, fertility tests, HPV tests, and wellness tests for cholesterol and diabetes. The company pivoted during the pandemic to provide COVID-19 testing kits after securing FDA approval. LetsGetChecked reached unicorn status in June 2021 following a $150 million Series D round led by Casdin Capital. In August 2022, approximately two years later, the company raised $20 million in a Series D2 funding round from returning investors Casdin Capital and Transformation Capital. This follow-on investment supported the company's growth and operations. The company subsequently announced plans to acquire digital pharmacy provider Truepill in a deal valued at $525 million, with $25 million in cash and the remainder in stock, plus potential earnouts of $200 million tied to revenue milestones.
Jun 2021Series DCasdin Capital (lead); Illumina Ventures; HLM Venture Partners; Symphony Ventures; Synetro Group; Qiming Venture Partners USA; Common Fund; Optum Ventures; Transformation Capital$150M$1BLetsGetChecked is a Dublin- and New York-based at-home testing company offering over 100 regulated lab tests for conditions like cholesterol, diabetes, sexual health, and COVID-19, with results delivered via a secure portal. The company raised a $150 million Series D round on June 8, 2021, led by Casdin Capital, with participation from CommonFund Capital, Illumina Ventures, Optum Ventures, and others, bringing total funding to over $260 million and achieving unicorn status with a $1 billion post-money valuation. This funding supports expansion into broader virtual care, including telehealth consultations, video visits, prescription services for cholesterol and thyroid management, and acquisition of a Florida pharmacy. Around the time of the round, LetsGetChecked reported revenue growth exceeding 1,500% year-over-year, reached over 1 million patients, and added health plans, employers, and government organizations as customers, fueled by pandemic-driven demand for at-home diagnostics like its FDA-authorized COVID-19 PCR test manufactured and analyzed in-house. The platform emphasizes end-to-end remote care, connecting users to labs, telehealth providers, and now pharmaceutical services. Competitors like Everlywell pursued similar expansions, such as acquiring telehealth providers. Post-round, LetsGetChecked continued developing comprehensive virtual care capabilities amid a diagnostics market boosted by the pandemic, planning new tests and clinician interactions to reduce in-person visits.
May 2020Series CHLM Venture Partners (lead); Illumina Ventures (lead); Qiming Venture Partners USA; Common Fund; Optum Ventures; Transformation Capital; Deerfield; Angeles Investment Advisors, LLC$71M-LetsGetChecked, a direct-to-consumer at-home health testing company founded in 2015 with offices in Dublin and New York City, closed an oversubscribed $71 million Series C funding round on May 6, 2020, co-led by Illumina Ventures and HLM Venture Partners. New investors included Deerfield, CommonFund Capital, and Angeles Investment Advisors, while returning participants were Transformation Capital, Optum Ventures, and Qiming Venture Partners USA. Nick Naclerio from Illumina Ventures and Steven Tolle from HLM Venture Partners joined the board. The funding was aimed at increasing manufacturing, supply, and testing capacity for COVID-19, scaling operations at its CLIA-certified lab in California, expanding business across the US and Europe, and deepening partnerships with insurers and employers. At the time, the company was delivering tens of thousands of COVID-19 tests per day to frontline healthcare workers, alongside its existing portfolio of at-home tests for conditions like sexual health, fertility, diabetes, cholesterol, cancer screening, vitamin deficiencies, herpes, hepatitis, and pharmacogenomics. LetsGetChecked had previously raised $30 million in a Series B round in May 2019 led by Leerink Transformation Partners with Optum Ventures and others. The Series C came amid surging demand for home diagnostics during the COVID-19 pandemic, which CEO Peter Foley noted had legitimized the sector, with spikes in testing for various monitored health conditions beyond COVID-19. The company connects users to board-certified physicians for abnormal results and operates in the US, Canada, and Europe.
May 2019Series BLeerink Transformation Partners (lead); Qiming Venture Partners; Optum Ventures$30M-LetsGetChecked is a direct-to-consumer diagnostic startup offering at-home lab testing kits for conditions including STDs, fertility issues, colon cancer, and Celiac disease. Customers purchase kits online or through retail partners like CVS and Walmart, collect samples at home, and mail them back for processing via certified reference labs, with results and clinical support provided. Founded in 2014 by Peter Foley, the company operates in the U.S., Canada, and Europe, focusing on personalized health management and accessibility to routine screenings. In May 2019, LetsGetChecked raised a $30 million Series B funding round led by Leerink Transformation Partners (LTP), with participation from existing investors Optum Ventures and Qiming Venture Partners USA. This brought total funding to around $42 million at the time. The capital was earmarked for scaling operations, expanding the core technology platform, and enhancing U.S. manufacturing and logistical capabilities to support growth amid rising demand for at-home testing. Leerink Transformation Partners, co-founded by Todd Cozzens and Jared Kesselheim in 2016, managed a $313 million fund investing in digital health companies like LetsGetChecked. LTP later transitioned to Transformation Capital in 2019 following SVB's acquisition of Leerink businesses, with Cozzens becoming chairman of LetsGetChecked's board. The company competes in a crowded at-home testing market against players like Everlywell (which raised $50M around the same time), MyLabBox, Thorne, Healthy.io, 23andMe, and Helix. LetsGetChecked differentiates through its end-to-end model integrating testing, logistics, results, and professional guidance.
Mar 2018Series AOptum Ventures (lead); Qiming Venture Partners (lead); Elkstone Capital Partners$12M--

Who has invested in LetsGetChecked?

16 investors have backed LetsGetChecked across its funding rounds, including Optum Ventures, Illumina Ventures, Transformation Capital, Common Fund, Qiming Venture Partners and Casdin Capital.

Lead investors include Optum Ventures, Casdin Capital, Transformation Capital, HLM Venture Partners, Illumina Ventures and 2 other investors.


LetsGetChecked Investors

Investors in LetsGetChecked by funding rounds participated
InvestorHQRoundsRoleFirst check
Optum VenturesUnited StatesBoston, MA5LeadMar 2018
Illumina VenturesUnited StatesSan Francisco, CA3LeadMay 2020
Common FundUnited StatesNorwalk, CT3ParticipantMay 2020
Transformation CapitalUnited StatesBoston, MA3LeadMay 2020
HLM Venture PartnersUnited StatesBoston, MA2LeadMay 2020
Casdin CapitalUnited StatesNew York City, NY2LeadJun 2021
Qiming Venture PartnersChinaShanghai2LeadMar 2018
Qiming Venture Partners USAUnited StatesUnited States2ParticipantMay 2020
Rory McIlroyIrelandIreland1ParticipantSep 2022
Symphony VenturesIrelandDublin1ParticipantJun 2021
Leerink Transformation PartnersUnited StatesBoston, MA1LeadMay 2019
Synetro GroupUnited StatesChicago, IL1ParticipantJun 2021
Morgan HealthUnited StatesNew York City, NY1ParticipantSep 2022

This data is available for Pro users. Sign up to see all 16 LetsGetChecked investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

Acquisitions by LetsGetChecked

LetsGetChecked has acquired 4 companies to date.

Last acquisition by LetsGetChecked was on August 21st 2024. LetsGetChecked acquired Truepill for $525M.


Latest Acquisitions by LetsGetChecked

Truepill
Veritas Genetics
Veritas Intercontinental
BioIQ
Description
Truepill is a San Mateo-headquartered B2B pharmacy fulfillment service operating labs in California and Nevada shipping to all 50 US states. It provides APIs for prescription management serving Hims, Nurx, and Cerebral with automated dispensing of 1 million orders monthly. Truepill handles prior authorizations and compounding for GLP-1 drugs like Ozempic alternatives. The 400-employee company raised $180 million from Initialized Capital and Y Combinator. Founded in 2016, it processes 20 percent of US digital prescriptions.
Veritas Genetics is a Boston-based biotechnology firm offering whole-genome sequencing services through its proprietary analytic platform. The company provides the myGenome test that sequences the entire human genome to identify genetic risks for hereditary breast and ovarian cancer as well as other conditions. Its technology detects a broader range of gene variations compared to standard next-generation sequencing methods. Veritas Genetics serves clinical researchers and physicians worldwide with data interpretation tools for personalized medicine applications.
Veritas Intercontinental is a Singapore-headquartered genomics company delivering whole genome sequencing and interpretation services since 2018. Launched as an international arm of Veritas Genetics founded in 2014, it sequences 100% of the human genome for consumers and physicians at reduced costs. The firm earned MIT Technology Review's 50 Smartest Companies recognition in 2016 and 2017.
BioIQ, also known as Jentryx, is a health technology firm delivering integrated wellness platforms across the United States. Established in 2005, it provides customizable health screening tools and ecosystems for corporate programs, enabling measurable outcomes for employers and health companies. BioIQ has deployed over 3,000 initiatives, focusing on biometric screenings and improvement methodologies to optimize wellness investments nationwide.
HQ CountryUnited StatesUnited StatesSpainUnited States
HQ City
San Francisco, CA
Boston, MA
Madrid
Santa Barbara, CA
Deal Date21 Aug 202429 Mar 202229 Mar 202216 Nov 2021
Valuation$525Mundisclosedundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all LetsGetChecked acquisitions and their M&A valuation multiples.

Start Free Trial

LetsGetChecked Competitors

LetsGetChecked competitors include listed companies like Detection Technology, Clinica Baviera, Wandong Medical and Castle Biosciences, and private ones like Scivita Medical Technology and Carestream.

Public and private companies comparable to LetsGetChecked
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
Detection TechnologyFinlandFinlandPublicly listed$116M$11M$125M0.9x
Clinica BavieraSpainSpainPublicly listed$347M$97M$1B2.7x
Scivita Medical TechnologyChinaSuzhouPrivate--$1.1B-
Wandong MedicalChinaChinaPublicly listed$201M($46M)$1.1B3.3x
Castle BiosciencesUnited StatesUnited StatesPublicly listed$344M($429K)$1.1B2.3x
CarestreamChinaShanghaiPrivate--$800M-

LetsGetChecked Public Comps

LetsGetChecked is still privately-owned, but its public comps include Clinica Baviera, Lumexa Imaging, Wandong Medical, Castle Biosciences, Guangzhou Wondfo Biotech, Daan Gene, Innovita Biological Tech, SonoScape, Varex Imaging and Diagnósticos da América.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Clinica Baviera$347M$97M2.9x2.7x10.2x9.4x
Lumexa Imaging$1B$142M1.9x1.9x13.9x8.3x
Wandong Medical$201M($46M)3.2x3.3x(14.2x)-
Castle Biosciences$344M($429K)2.5x2.3x(1980.1x)42.8x
Guangzhou Wondfo Biotech$311M$26M2.9x3.0x34.8x13.6x
Daan Gene$113M($75M)8.9x-(13.4x)-
Innovita Biological Tech$63M$27M14.3x14.5x33.4x37.9x
SonoScape$345M$35M3.2x2.9x30.9x25.0x

This data is available for Pro users. Sign up to see all LetsGetChecked competitors and their valuation data.

Start Free Trial

Common questions about LetsGetChecked

When was LetsGetChecked founded?LetsGetChecked was founded in 2015.
Where is LetsGetChecked headquartered?LetsGetChecked is headquartered in Atlanta, GA, United States.
Is LetsGetChecked publicly listed?No, LetsGetChecked is a private, VC-backed company.
What is LetsGetChecked's valuation?LetsGetChecked was last valued at $1B in its Series D in June 2021.
How much funding has LetsGetChecked raised?LetsGetChecked has raised $598M across 7 funding rounds.
What was LetsGetChecked's last funding round?LetsGetChecked's last funding round was a $165M Series F in January 2025, led by Optum Ventures.
Who are LetsGetChecked's investors?LetsGetChecked's investors include Optum Ventures, Illumina Ventures, Common Fund, Transformation Capital, HLM Venture Partners, Casdin Capital, Qiming Venture Partners, Qiming Venture Partners USA, Rory McIlroy, Symphony Ventures and 6 others.
Which companies are comparable to LetsGetChecked?Companies comparable to LetsGetChecked include Detection Technology, Clinica Baviera, Scivita Medical Technology, Wandong Medical, Castle Biosciences and Carestream.
How many companies has LetsGetChecked acquired?LetsGetChecked has acquired 4 companies, including Truepill, Veritas Genetics, Veritas Intercontinental and BioIQ.
What was the largest acquisition by LetsGetChecked?The $525M acquisition of Truepill in August 2024 is the largest acquisition LetsGetChecked has made to date.

See companies similar to LetsGetChecked

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial